Low-dose lithium prevents age-dependent metabolic stress–driven alzheimer’s disease–like pathology through restoration of the NAMPT–NAD⁺–SIRT1–AMPK–TFEB metabolic resilience network
Low-dose lithium prevents age-dependent Alzheimer's disease-like pathology induced by metabolic stress by restoring the NAMPT–NAD⁺–SIRT1–AMPK metabolic resilience network, which subsequently reactivates TFEB-mediated lysosomal-autophagic function to improve cognitive performance and reduce neurodegeneration.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human brain is a demanding organ, constantly consuming energy to keep thoughts flowing and memories intact. As we age, the body's ability to manage this energy supply and repair cellular wear and tear naturally declines. This decline in what scientists call metabolic resilience—the capacity of cells to bounce back from stress—makes the aging brain more vulnerable to damage. When the brain cannot handle metabolic stress, such as that caused by poor diet or high blood sugar, it can trigger a cascade of events that resemble the early stages of Alzheimer's disease. This includes the buildup of toxic proteins and the loss of connections between nerve cells, leading to memory loss and confusion. Understanding how to restore this metabolic resilience in older brains is a critical goal for preventing dementia, as it addresses the root cause of vulnerability rather than just treating the symptoms.
A team of researchers set out to investigate whether a simple, low dose of lithium, a mineral commonly known for treating mood disorders, could repair this broken metabolic system in aging mice. They focused on a specific chain of molecular signals that acts as a central hub for cellular energy and cleanup: a network involving an enzyme called NAMPT, a vital fuel molecule known as NAD+, and two protein regulators named SIRT1 and AMPK. In a healthy young brain, this network helps cells adapt to stress and clear out damaged components. The researchers wanted to see if this network collapses under the pressure of metabolic stress in older animals and if lithium could rebuild it. To test this, they fed young and old mice a high-fat, high-calorie diet for sixteen weeks to simulate the metabolic strain of an unhealthy lifestyle. Some of these mice also received a daily, low dose of lithium administered by oral gavage, while others did not.
The results showed that the high-fat diet caused significant problems for the mice, but the impact was far worse for the older ones. The older mice struggled much more to learn and remember the location of a hidden platform in a water maze, a standard test for spatial memory, and they performed poorly in tests of working memory and object recognition. Inside their brains, the high-fat diet had disrupted the metabolic resilience network. Levels of the crucial fuel molecule NAD+ dropped, and the activity of the protective proteins SIRT1 and AMPK fell, while signals that promote aging and inflammation rose. This breakdown led to a failure in the brain's internal cleanup crew, known as lysosomes and autophagy, which are responsible for recycling damaged proteins and organelles. Consequently, toxic proteins associated with Alzheimer's disease, such as amyloid-beta and hyperphosphorylated tau, began to accumulate. The older mice also showed signs of increased cellular aging, heightened inflammation, and a loss of the synaptic connections that allow brain cells to communicate.
When the researchers introduced low-dose lithium to the mix, the outcome changed dramatically. The lithium-treated mice, particularly the older ones, showed a remarkable recovery in their ability to learn and remember. In the water maze, they found the hidden platform much faster than the untreated older mice. At a molecular level, the lithium appeared to act as a reset button for the metabolic network. It restored the levels of NAMPT and NAD+, reactivated the SIRT1 and AMPK proteins, and improved the brain's energy production. This restoration allowed the brain's cleanup systems to function again, clearing out the toxic protein clumps and reducing the accumulation of damaged cellular parts. The lithium also calmed the brain's inflammatory response, reduced the number of aging cells, and preserved the structural integrity of the synapses. The treatment was so effective that the older mice treated with lithium performed significantly better than their untreated counterparts, though they did not fully return to the levels of the young, healthy controls.
To confirm that lithium was working specifically through this metabolic pathway, the researchers used drugs to block the activity of SIRT1 and AMPK in some of the treated mice. When these specific pathways were blocked, the protective effects of lithium disappeared. The mice no longer showed improvements in their cleanup systems or their memory, proving that the drug's success depended entirely on reactivating this specific chain of signals. The study concludes that the collapse of the NAMPT–NAD+–SIRT1–AMPK network is a key driver of age-related vulnerability to metabolic stress and Alzheimer's-like pathology. By restoring this network, low-dose lithium helps the aging brain regain its ability to handle stress, clear out toxic waste, and maintain the connections necessary for memory. While this research was conducted in mice and does not yet prove the same effects in humans, it identifies a promising new angle for understanding how to protect the aging brain by strengthening its fundamental metabolic resilience.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.